Apogee Therapeutics APGE
APGE
$135.07 +1.11 (+0.83%)
At close: Sep 2, 2026 · 4:00 PM EDT

Apogee Therapeutics (APGE) Capital Expenditures (2024 - 2025)

Updated

Apogee Therapeutics (APGE) reported Capital Expenditures of $62,000 for Q4 2025, compared with -$1,000 a year earlier.

Analysis

Apogee Therapeutics (APGE) Capital Expenditures (2024 - 2025) Analysis & Trends

For FY2025, Apogee Therapeutics posted Capital Expenditures of $5.15 million, up 346.8% from FY2024.

  • By year, Capital Expenditures came in at $1.15 million in FY2024 (+589.8%) and $167,000 in FY2023.
  • Five-year quarterly Capital Expenditures spans a low of -$1,000 in Q4 2024 and a high of $4.32 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Apogee Therapeutics 10.18 Bn 7.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 62,000.00
Jun 30, 2025 768,000.00
Mar 31, 2025 4.32 Mn
Dec 31, 2024 -1,000.00
Sep 30, 2024 751,000.00
Jun 30, 2024 51,000.00
Mar 31, 2024 351,000.00
API Access

Apogee Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=APGE&period=max&api_key=YOUR_API_KEY